Name | Number of supported studies | Average coverage | |
---|---|---|---|
erythrocyte | 15 studies | 60% ± 19% | |
microglial cell | 13 studies | 31% ± 10% | |
glutamatergic neuron | 12 studies | 56% ± 22% | |
oligodendrocyte | 12 studies | 29% ± 12% | |
endothelial cell of lymphatic vessel | 12 studies | 28% ± 11% | |
platelet | 9 studies | 47% ± 15% | |
neuron | 8 studies | 32% ± 11% | |
GABAergic neuron | 8 studies | 25% ± 10% | |
oligodendrocyte precursor cell | 8 studies | 27% ± 11% | |
basal cell | 7 studies | 23% ± 7% | |
macrophage | 7 studies | 32% ± 9% | |
retinal ganglion cell | 6 studies | 70% ± 26% | |
megakaryocyte | 5 studies | 67% ± 25% | |
endothelial cell | 5 studies | 38% ± 12% | |
mesothelial cell | 5 studies | 33% ± 13% | |
melanocyte | 5 studies | 51% ± 15% | |
podocyte | 4 studies | 40% ± 9% | |
erythroblast | 4 studies | 60% ± 34% | |
glial cell | 4 studies | 27% ± 10% | |
granule cell | 4 studies | 39% ± 9% | |
GABAergic amacrine cell | 4 studies | 31% ± 10% | |
fibroblast | 4 studies | 25% ± 7% | |
amacrine cell | 4 studies | 36% ± 15% | |
myeloid cell | 4 studies | 21% ± 3% | |
conventional dendritic cell | 3 studies | 23% ± 1% | |
retinal pigment epithelial cell | 3 studies | 34% ± 16% | |
Schwann cell | 3 studies | 37% ± 14% | |
interneuron | 3 studies | 29% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 6371.13 | 2625 / 2642 | 91% | 14.67 | 641 / 705 |
prostate | 64% | 608.84 | 157 / 245 | 77% | 5.03 | 385 / 502 |
skin | 38% | 293.51 | 682 / 1809 | 97% | 44.82 | 458 / 472 |
uterus | 88% | 1425.24 | 150 / 170 | 29% | 1.87 | 134 / 459 |
ovary | 87% | 1008.02 | 157 / 180 | 20% | 0.77 | 84 / 430 |
eye | 0% | 0 | 0 / 0 | 86% | 13.81 | 69 / 80 |
lung | 52% | 431.11 | 298 / 578 | 32% | 1.92 | 366 / 1155 |
peripheral blood | 78% | 4096.06 | 729 / 929 | 0% | 0 | 0 / 0 |
adrenal gland | 3% | 27.66 | 8 / 258 | 61% | 6.54 | 141 / 230 |
esophagus | 38% | 349.47 | 553 / 1445 | 23% | 1.03 | 42 / 183 |
intestine | 55% | 683.17 | 535 / 966 | 6% | 0.30 | 30 / 527 |
kidney | 26% | 198.33 | 23 / 89 | 22% | 1.15 | 199 / 901 |
thymus | 14% | 101.30 | 93 / 653 | 27% | 1.16 | 164 / 605 |
tonsil | 0% | 0 | 0 / 0 | 36% | 2.39 | 16 / 45 |
bladder | 19% | 121.00 | 4 / 21 | 14% | 0.79 | 73 / 504 |
adipose | 29% | 255.80 | 349 / 1204 | 0% | 0 | 0 / 0 |
spleen | 29% | 315.32 | 69 / 241 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0 | 0 / 328 | 27% | 1.33 | 48 / 178 |
breast | 12% | 82.73 | 56 / 459 | 7% | 0.22 | 80 / 1118 |
stomach | 12% | 103.73 | 42 / 359 | 6% | 0.28 | 18 / 286 |
heart | 9% | 60.30 | 75 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 7% | 62.56 | 90 / 1335 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 1% | 0.08 | 5 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0031623 | Biological process | receptor internalization |
GO_0048488 | Biological process | synaptic vesicle endocytosis |
GO_0010040 | Biological process | response to iron(II) ion |
GO_0051585 | Biological process | negative regulation of dopamine uptake involved in synaptic transmission |
GO_0006638 | Biological process | neutral lipid metabolic process |
GO_0071872 | Biological process | cellular response to epinephrine stimulus |
GO_0010517 | Biological process | regulation of phospholipase activity |
GO_0060732 | Biological process | positive regulation of inositol phosphate biosynthetic process |
GO_1903426 | Biological process | regulation of reactive oxygen species biosynthetic process |
GO_0051262 | Biological process | protein tetramerization |
GO_0042416 | Biological process | dopamine biosynthetic process |
GO_0051402 | Biological process | neuron apoptotic process |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0051621 | Biological process | regulation of norepinephrine uptake |
GO_0016082 | Biological process | synaptic vesicle priming |
GO_1903285 | Biological process | positive regulation of hydrogen peroxide catabolic process |
GO_0001956 | Biological process | positive regulation of neurotransmitter secretion |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0045920 | Biological process | negative regulation of exocytosis |
GO_0035543 | Biological process | positive regulation of SNARE complex assembly |
GO_0014059 | Biological process | regulation of dopamine secretion |
GO_0006919 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_1904377 | Biological process | positive regulation of protein localization to cell periphery |
GO_0032026 | Biological process | response to magnesium ion |
GO_0007006 | Biological process | mitochondrial membrane organization |
GO_0060291 | Biological process | long-term synaptic potentiation |
GO_0006631 | Biological process | fatty acid metabolic process |
GO_0042775 | Biological process | mitochondrial ATP synthesis coupled electron transport |
GO_0006644 | Biological process | phospholipid metabolic process |
GO_0050729 | Biological process | positive regulation of inflammatory response |
GO_0043154 | Biological process | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0010642 | Biological process | negative regulation of platelet-derived growth factor receptor signaling pathway |
GO_0051612 | Biological process | negative regulation of serotonin uptake |
GO_0006469 | Biological process | negative regulation of protein kinase activity |
GO_0048169 | Biological process | regulation of long-term neuronal synaptic plasticity |
GO_0001774 | Biological process | microglial cell activation |
GO_0032410 | Biological process | negative regulation of transporter activity |
GO_1904715 | Biological process | negative regulation of chaperone-mediated autophagy |
GO_0060079 | Biological process | excitatory postsynaptic potential |
GO_0031115 | Biological process | negative regulation of microtubule polymerization |
GO_0033138 | Biological process | positive regulation of peptidyl-serine phosphorylation |
GO_0045807 | Biological process | positive regulation of endocytosis |
GO_0032769 | Biological process | negative regulation of monooxygenase activity |
GO_0031648 | Biological process | protein destabilization |
GO_0034341 | Biological process | response to type II interferon |
GO_0097435 | Biological process | supramolecular fiber organization |
GO_0034599 | Biological process | cellular response to oxidative stress |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_1903421 | Biological process | regulation of synaptic vesicle recycling |
GO_0051281 | Biological process | positive regulation of release of sequestered calcium ion into cytosol |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_0050808 | Biological process | synapse organization |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0045921 | Biological process | positive regulation of exocytosis |
GO_0050812 | Biological process | regulation of acyl-CoA biosynthetic process |
GO_0055074 | Biological process | calcium ion homeostasis |
GO_0001921 | Biological process | positive regulation of receptor recycling |
GO_1905606 | Biological process | regulation of presynapse assembly |
GO_0051622 | Biological process | negative regulation of norepinephrine uptake |
GO_0008344 | Biological process | adult locomotory behavior |
GO_0051583 | Biological process | dopamine uptake involved in synaptic transmission |
GO_0043030 | Biological process | regulation of macrophage activation |
GO_0016079 | Biological process | synaptic vesicle exocytosis |
GO_0014048 | Biological process | regulation of glutamate secretion |
GO_0070555 | Biological process | response to interleukin-1 |
GO_1902957 | Biological process | negative regulation of mitochondrial electron transport, NADH to ubiquinone |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0035493 | Biological process | SNARE complex assembly |
GO_1903284 | Biological process | positive regulation of glutathione peroxidase activity |
GO_1990000 | Biological process | amyloid fibril formation |
GO_0071280 | Biological process | cellular response to copper ion |
GO_0070495 | Biological process | negative regulation of thrombin-activated receptor signaling pathway |
GO_0040012 | Biological process | regulation of locomotion |
GO_0071902 | Biological process | positive regulation of protein serine/threonine kinase activity |
GO_0022898 | Biological process | regulation of transmembrane transporter activity |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0048489 | Biological process | synaptic vesicle transport |
GO_0099512 | Cellular component | supramolecular fiber |
GO_0043679 | Cellular component | axon terminus |
GO_0098794 | Cellular component | postsynapse |
GO_0043025 | Cellular component | neuronal cell body |
GO_0005634 | Cellular component | nucleus |
GO_0005576 | Cellular component | extracellular region |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0005615 | Cellular component | extracellular space |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0005764 | Cellular component | lysosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0016234 | Cellular component | inclusion body |
GO_0005737 | Cellular component | cytoplasm |
GO_0030424 | Cellular component | axon |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0030672 | Cellular component | synaptic vesicle membrane |
GO_0031092 | Cellular component | platelet alpha granule membrane |
GO_0005829 | Cellular component | cytosol |
GO_0005938 | Cellular component | cell cortex |
GO_0030426 | Cellular component | growth cone |
GO_0004860 | Molecular function | protein kinase inhibitor activity |
GO_0008198 | Molecular function | ferrous iron binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0048156 | Molecular function | tau protein binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0019894 | Molecular function | kinesin binding |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0042393 | Molecular function | histone binding |
GO_0060961 | Molecular function | phospholipase D inhibitor activity |
GO_0016491 | Molecular function | oxidoreductase activity |
GO_0030544 | Molecular function | Hsp70 protein binding |
GO_0003779 | Molecular function | actin binding |
GO_0008289 | Molecular function | lipid binding |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0005504 | Molecular function | fatty acid binding |
GO_0005507 | Molecular function | copper ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0043027 | Molecular function | cysteine-type endopeptidase inhibitor activity involved in apoptotic process |
GO_0005543 | Molecular function | phospholipid binding |
GO_0000149 | Molecular function | SNARE binding |
GO_0043014 | Molecular function | alpha-tubulin binding |
GO_0070840 | Molecular function | dynein complex binding |
GO_1903136 | Molecular function | cuprous ion binding |
GO_0051219 | Molecular function | phosphoprotein binding |
Gene name | SNCA |
Protein name | Alpha-synuclein Alpha-synuclein (Non-A beta component of AD amyloid) (Non-A4 component of amyloid precursor) (NACP) Synuclein alpha |
Synonyms | NACP PARK1 hCG_1777783 |
Description | FUNCTION: Neuronal protein that plays several roles in synaptic activity such as regulation of synaptic vesicle trafficking and subsequent neurotransmitter release . Participates as a monomer in synaptic vesicle exocytosis by enhancing vesicle priming, fusion and dilation of exocytotic fusion pores . Mechanistically, acts by increasing local Ca(2+) release from microdomains which is essential for the enhancement of ATP-induced exocytosis . Acts also as a molecular chaperone in its multimeric membrane-bound state, assisting in the folding of synaptic fusion components called SNAREs (Soluble NSF Attachment Protein REceptors) at presynaptic plasma membrane in conjunction with cysteine string protein-alpha/DNAJC5 . This chaperone activity is important to sustain normal SNARE-complex assembly during aging . Also plays a role in the regulation of the dopamine neurotransmission by associating with the dopamine transporter (DAT1) and thereby modulating its activity . . |
Accessions | ENST00000674129.1 ENST00000506244.5 [P37840-1] H6UYS0 ENST00000345009.8 [P37840-2] ENST00000394986.5 [P37840-1] ENST00000506691.1 ENST00000508895.5 [P37840-1] E7EPV7 H6UYS5 P37840 ENST00000505199.5 [P37840-3] ENST00000336904.7 [P37840-1] ENST00000611107.1 D6RA31 ENST00000394989.6 [P37840-3] ENST00000673718.1 [P37840-1] ENST00000618500.4 [P37840-3] ENST00000420646.6 [P37840-2] A0A669KB41 H6UYS7 ENST00000394991.8 [P37840-1] ENST00000673902.1 ENST00000502987.5 Q4W5L2 A0A669KBH5 |